GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (HKSE:02269) » Definitions » Short Interest

WuXi Biologics (Cayman) (HKSE:02269) Short Interest


View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of WuXi Biologics (Cayman)'s Short Interest

For the Biotechnology subindustry, WuXi Biologics (Cayman)'s Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WuXi Biologics (Cayman)'s Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s Short Interest distribution charts can be found below:

* The bar in red indicates where WuXi Biologics (Cayman)'s Short Interest falls into.



WuXi Biologics (Cayman) Business Description

Traded in Other Exchanges
Address
No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 17 billion. North America represented 47.4% of total revenue in 2023. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.
Executives
Blackrock, Inc. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Li Ge 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Brown Brothers Harriman & Co. 2502 Approved lending agent
Zhao Ning 2202 Interest of your spouse
Liu Xiaozhong 2401 A concert party to an agreement to buy shares
New Wuxi Life Science Holdings Limited 2201 Interest of corporation controlled by you
New Wuxi Life Science Limited 2201 Interest of corporation controlled by you
Wuxi Biologics Holdings Limited 2101 Beneficial owner
Wuxi Pharmatech (cayman) Inc. 2201 Interest of corporation controlled by you
Zhang Zhaohui 2401 A concert party to an agreement to buy shares
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you

WuXi Biologics (Cayman) Headlines

No Headlines